Genetic modifiers in rare disorders: the case of fragile X syndrome

Eur J Hum Genet. 2021 Jan;29(1):173-183. doi: 10.1038/s41431-020-00711-x. Epub 2020 Aug 29.

Abstract

Methods employed in genome-wide association studies are not feasible ways to explore genotype-phenotype associations in rare disorders due to limited statistical power. An alternative approach is to examine relationships among specific single nucleotide polymorphisms (SNPs), selected a priori, and behavioural characteristics. Here, we adopt this strategy to examine relationships between three SNPs (5-HTTLPR, MAOA, COMT) and specific clinically-relevant behaviours that are phenotypic of fragile X syndrome (FXS) but vary in severity and frequency across individuals. Sixty-four males with FXS participated in the current study. Data from standardised informant measures of challenging behaviour (defined as physical aggression, property destruction, stereotyped behaviour, and self-injury), autism symptomatology, attention-deficit-hyperactivity-disorder characteristics, repetitive behaviour and mood/interest and pleasure were compared between each SNP genotype. No association was observed between behavioural characteristics and either 5-HTTLPR (serotonin) or MAOA (monoamine oxidase) genotypes. However, compared to the COMT (dopamine) AG and GG genotypes, the AA genotype was associated with greater interest and pleasure in the environment, and with reduced risk for property destruction, stereotyped behaviour and compulsive behaviour. The results suggest that common genetic variation in the COMT genotype affecting dopamine levels in the brain may contribute to the variability of challenging and repetitive behaviours and interest and pleasure in this population. This study identifies a role for additional genetic risk in understanding the neural and genetic mechanisms contributing to phenotypic variability in neurodevelopmental disorders, and highlights the merit of investigating SNPs that are selected a priori on a theoretical basis in rare populations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Catechol O-Methyltransferase / genetics
  • Child
  • Child, Preschool
  • Fragile X Syndrome / genetics*
  • Fragile X Syndrome / pathology
  • Genes, Modifier*
  • Humans
  • Monoamine Oxidase / genetics
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Problem Behavior
  • Serotonin Plasma Membrane Transport Proteins / genetics

Substances

  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • Monoamine Oxidase
  • monoamine oxidase A, human
  • COMT protein, human
  • Catechol O-Methyltransferase